Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thumb spica cast after methylprednisolone injection for De Quervain disease
IRCT20240122060766N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methylprednisolone and lidocaine in nonsuppurative thyroiditis (2 arms), sponsored by Islamic Azad University. Primary endpoints: Improvement of symptoms and pain of the patient's thumb, Visual Analog Scale score and 1 more. Started Jan 2024; status: completed.
02
Drugs
methylprednisolonelidocaine
03
Conditions
nonsuppurative thyroiditis
Beyond the preview
Go deeper on IRCT20240122060766N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240122060766N1.